Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430898
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-01-31
Brief Title:
Basiliximab in Moderate to Severe Ulcerative Colitis
Sponsor:
Cerimon Pharmaceuticals
Organization:
Cerimon Pharmaceuticals
Organization Data
Organization:
Cerimon Pharmaceuticals
Class:
INDUSTRY
Study ID:
BSX-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cerimon Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Cerimon Pharmaceuticals Inc
Old Organization:
Cerimon Pharmaceuticals Inc